Literature DB >> 8389310

Lactate and pH in faeces from patients with colonic adenomas or cancer.

H Hove1, M Rye Clausen, P Brøbech Mortensen.   

Abstract

Earlier studies have reported that faecal pH is more alkaline in patients with colonic cancer, indicating a reduction in colonic carbohydrate fermentation to organic acids. The pH of faeces from 11 pre and 14 postoperative, selected colonic cancer patients without intestinal obstruction, major loss of appetite or weight, not treated with antibiotics, and without signs of dissemination or recurrence of the cancer, did not differ, however, from faecal pH in 17 patients with previous colonic adenomas removed by polypectomy and faecal pH in 17 age matched (mean 61 years) healthy controls (mean (SE) 7.03 (0.10), 7.15 (0.11), 7.20 (0.12), 7.11 (0.12) respectively; p = 0.82). Faecal pH in 20 younger (mean 32 years) healthy controls tended to be lower (6.89 (0.07) compared with the older age matched control group (p < 0.06). Faecal concentrations of D-, L- or total D+L-lactate did not differ between the patients with present or previous colonic cancer, adenomas, and the healthy controls (D+L-lactate mean (SE) 3.2 (0.5), 3.1 (0.3), 3.5 (0.7), 4.1 (1.0) mmol/l respectively; p = 0.72), and the production pattern of lactate from different carbohydrates (glucose and dietary fibre) in 16.6% faecal homogenates was similar in all the three groups of patients and the healthy controls. Faecal pH was changed within days by modifications of the diet. An enteral diet free of fibre, starch, and lactose increased faecal pH within three days, whereas pH decreased when the colonic load of carbohydrates was increased by lactulose. Therefore, the reported alkaline faecal pH in patients with colonic cancer may reflect short term reduction in dietary intake and colonic fermentation secondary to the presence of the cancer, especially in patients with advanced disease, rather than long term differences in the precancer dietary habits.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8389310      PMCID: PMC1374179          DOI: 10.1136/gut.34.5.625

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  25 in total

1.  ACQUIRED MILK INTOLERANCE IN THE ADULT CAUSED BY LACTOSE MALABSORPTION DUE TO A SELECTIVE DEFICIENCY OF INTESTINAL LACTASE ACTIVITY.

Authors:  U P HAEMMERLI; H KISTLER; R AMMANN; T MARTHALER; G SEMENZA; S AURICCHIO; A PRADER
Journal:  Am J Med       Date:  1965-01       Impact factor: 4.965

2.  Colonic pH: a comparison between patients with colostomies due to trauma and colorectal cancer.

Authors:  D Charalambides; I Segal
Journal:  Am J Gastroenterol       Date:  1992-01       Impact factor: 10.864

3.  President's address. The polyp-cancer sequence in the large bowel.

Authors:  B Morson
Journal:  Proc R Soc Med       Date:  1974-06

4.  Epidemiology of cancer of the colon and rectum.

Authors:  D P Burkitt
Journal:  Cancer       Date:  1971-07       Impact factor: 6.860

5.  Role of life-style and dietary habits in risk of cancer among seventh-day adventists.

Authors:  R L Phillips
Journal:  Cancer Res       Date:  1975-11       Impact factor: 12.701

6.  Effects of lactulose and other laxatives on ileal and colonic pH as measured by a radiotelemetry device.

Authors:  R L Bown; J A Gibson; G E Sladen; B Hicks; A M Dawson
Journal:  Gut       Date:  1974-12       Impact factor: 23.059

7.  The degradation of amino acids, proteins, and blood to short-chain fatty acids in colon is prevented by lactulose.

Authors:  P B Mortensen; K Holtug; H Bonnén; M R Clausen
Journal:  Gastroenterology       Date:  1990-02       Impact factor: 22.682

8.  Colonic fermentation to short-chain fatty acids is decreased in antibiotic-associated diarrhea.

Authors:  M R Clausen; H Bonnén; M Tvede; P B Mortensen
Journal:  Gastroenterology       Date:  1991-12       Impact factor: 22.682

9.  Colonic fermentation of dietary fibre to short chain fatty acids in patients with adenomatous polyps and colonic cancer.

Authors:  M R Clausen; H Bonnén; P B Mortensen
Journal:  Gut       Date:  1991-08       Impact factor: 23.059

10.  [The pH and acidity of feces in colorectal neoplasms].

Authors:  K Bech; O Kronborg; K Engel; P Kildeberg
Journal:  Ugeskr Laeger       Date:  1990-01-15
View more
  6 in total

1.  Colonic methanogenesis in vivo and in vitro and fecal pH after resection of colorectal cancer and in healthy intact colon.

Authors:  Reetta Holma; Pia Osterlund; Ulla Sairanen; Mikko Blom; Merja Rautio; Riitta Korpela
Journal:  Int J Colorectal Dis       Date:  2011-10-18       Impact factor: 2.571

2.  Increasing butyrate concentration in the distal colon by accelerating intestinal transit.

Authors:  S J Lewis; K W Heaton
Journal:  Gut       Date:  1997-08       Impact factor: 23.059

3.  Bile acid concentrations, cytotoxicity, and pH of fecal water from patients with colorectal adenomas.

Authors:  T M de Kok; A van Faassen; B Glinghammar; D M Pachen; M Eng; J J Rafter; C G Baeten; L G Engels; J C Kleinjans
Journal:  Dig Dis Sci       Date:  1999-11       Impact factor: 3.199

4.  Impact of the metabolic activity of Streptococcus thermophilus on the colon epithelium of gnotobiotic rats.

Authors:  Françoise Rul; Leila Ben-Yahia; Fatima Chegdani; Laura Wrzosek; Stéphane Thomas; Marie-Louise Noordine; Christophe Gitton; Claire Cherbuy; Philippe Langella; Muriel Thomas
Journal:  J Biol Chem       Date:  2011-01-14       Impact factor: 5.157

5.  Carbohydrate metabolism is essential for the colonization of Streptococcus thermophilus in the digestive tract of gnotobiotic rats.

Authors:  Muriel Thomas; Laura Wrzosek; Leila Ben-Yahia; Marie-Louise Noordine; Christophe Gitton; Didier Chevret; Philippe Langella; Camille Mayeur; Claire Cherbuy; Françoise Rul
Journal:  PLoS One       Date:  2011-12-22       Impact factor: 3.240

6.  Faecal D/L lactate ratio is a metabolic signature of microbiota imbalance in patients with short bowel syndrome.

Authors:  Camille Mayeur; Jean-Jacques Gratadoux; Chantal Bridonneau; Fatima Chegdani; Béatrice Larroque; Nathalie Kapel; Olivier Corcos; Muriel Thomas; Francisca Joly
Journal:  PLoS One       Date:  2013-01-23       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.